How a twice-shelved drug became the standard of care for the most widespread disease
Molecular models of the nucleotide analogue drug remdesivir (right) and its target the enzyme RNA-dependent RNA (ribonucleic acid) polymerase (RdRp, centre) from the SARS-CoV-2 coronavirus. JUAN GAERTNER/SCIENCE PHOTO LIBRARY/Getty Images
Remdesivir was the first medication approved for use in treating COVID-19 and one of the most expensive.
The drug is priced at $3,120 for a five-day treatment under private health insurance plans, and for U.S. government health programs, the cost is $2,340 per regimen.
Marina Zhang
Author
Marina Zhang is a health reporter for The Epoch Times. She covers both health news and in-depth features on emerging health issues. Marina holds a bachelor's degree in biomedicine from the University of Melbourne. Contact her at [email protected].
